These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31131989)

  • 1. Overrepresentation of Elderly Subjects in a Population-Based Study of Antiphospholipid Syndrome: Comment on the Article by Duarte-García et al.
    Gómez-Puerta JA; Cervera R; Alarcón GS
    Arthritis Rheumatol; 2019 Oct; 71(10):1768-1769. PubMed ID: 31131989
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiphospholipid Syndrome Is Still a Rare Disease-Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al.
    Radin M; Sciascia S; Bazzan M; Bertero T; Carignola R; Montabone E; Montaruli B; Vaccarino A; Cecchi I; Rubini E; Roccatello D; Baldovino S;
    Arthritis Rheumatol; 2020 Oct; 72(10):1774-1776. PubMed ID: 32840055
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al.
    Korkmaz C
    Arthritis Rheum; 2005 Mar; 52(3):988-9; author reply 989-90. PubMed ID: 15751054
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-Density Granulocytes Are Increased in Antiphospholipid Syndrome and Are Associated With Anti-β2 -Glycoprotein I Antibodies: Comment on the Article by Yalavarthi et al.
    van den Hoogen LL; Fritsch-Stork RD; van Roon JA; Radstake TR
    Arthritis Rheumatol; 2016 May; 68(5):1320-1. PubMed ID: 26749538
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on: "A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies" by Niccolai et al.
    Rodríguez-Carrio J; López Suárez P; Suárez Díaz A
    Thromb Res; 2016 Mar; 139():127. PubMed ID: 26916309
    [No Abstract]   [Full Text] [Related]  

  • 6. Unrealistic estimation of population prevalence of antiphospholipid antibody-related pregnancy loss: comment on the article by Andreoli et al.
    Clark CA; Laskin CA
    Arthritis Care Res (Hoboken); 2014 Jun; 66(6):966. PubMed ID: 24376042
    [No Abstract]   [Full Text] [Related]  

  • 7. Are Thrombotic Events in Dermatomyositis Related to The Effect of Antiphospholipid Antibodies? Comment on the Article by Moshtaghi-Svensson et al.
    Rothschild BM
    Arthritis Care Res (Hoboken); 2020 Mar; 72(3):459. PubMed ID: 31560452
    [No Abstract]   [Full Text] [Related]  

  • 8. Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al.
    Wahl D; Lecompte T; Bounameaux H
    Arthritis Rheum; 2008 Feb; 58(2):635-6; author reply 636. PubMed ID: 18240250
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiphospholipid antibodies and antiphospholipid syndrome: diagnosis and management].
    García-García C
    Actas Dermosifiliogr; 2007; 98(1):16-23. PubMed ID: 17374329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on: Kidney disease in primary antiphospholipid antibody syndrome.
    Korkmaz C; Cansu DU
    Rheumatology (Oxford); 2018 Feb; 57(2):403. PubMed ID: 29126313
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?
    Hopkinson NP; Lim K; Gardner-Medwin J
    Ann Rheum Dis; 1994 Sep; 53(9):619-20. PubMed ID: 7979605
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: comment.
    Pengo V
    J Thromb Haemost; 2016 Dec; 14(12):2561-2562. PubMed ID: 27638140
    [No Abstract]   [Full Text] [Related]  

  • 13. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
    Cervera R; Rodríguez-Pintó I; Colafrancesco S; Conti F; Valesini G; Rosário C; Agmon-Levin N; Shoenfeld Y; Ferrão C; Faria R; Vasconcelos C; Signorelli F; Espinosa G
    Autoimmun Rev; 2014 Jul; 13(7):699-707. PubMed ID: 24657970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome, antiphospholipid antibodies and solid organ transplantation.
    González-Moreno J; Callejas-Rubio JL; Ríos-Fernández R; Ortego-Centeno N
    Lupus; 2015 Nov; 24(13):1356-63. PubMed ID: 26162685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibodies and the endothelium.
    Hunt BJ; Khamashta MA
    Curr Rheumatol Rep; 2000 Jun; 2(3):252-5. PubMed ID: 11123067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibody profiling: association with the clinical phenotype of antiphospholipid syndrome? Comment on the article by Otomo et al.
    Roggenbuck D; Egerer K; Feist E; Burmester GR; Dörner T
    Arthritis Rheum; 2012 Aug; 64(8):2807-8; author reply 2808-9. PubMed ID: 22614803
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiphospholipid antibodies and the antiphospholipid antibody syndrome.
    Nahass GT
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):149-68; quiz 169-72. PubMed ID: 9039162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The scoring system for the risk-stratification in patients with the antiphospholipid syndrome].
    Oku K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):435-441. PubMed ID: 29367527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on: "The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome".
    Yazici A; Unlu O; Erkan D
    Thromb Res; 2017 Sep; 157():82-83. PubMed ID: 28711777
    [No Abstract]   [Full Text] [Related]  

  • 20. Laboratory criteria for antiphospholipid syndrome: comment.
    Lackner KJ; Müller-Calleja N
    J Thromb Haemost; 2018 Oct; 16(10):2115-2116. PubMed ID: 30007114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.